ArticleJournal for immunotherapy of cancer2025

Novel trispecific killer engager targeting B7-H3 enhances natural killer cell antitumor activity against head and neck cancer.

Melissa J Khaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.